Literature DB >> 24527777

A multiplex polymerase chain reaction method for the simultaneous detection of GSTM1, GSTT1, and GSTP1 polymorphisms.

Yan Deng1, Wei Cai, Jixiong Xu, Weifeng Zhu, Daya Luo, Wei Zhang, Weiwei Liu, Fusheng Wan, Jinglin Yi.   

Abstract

BACKGROUND: Glutathione S-transferases (GSTs) play an important role in the detoxification of a wide variety of toxicants. Among GSTs, GSTM1 and GSTT1 polymorphic deletions and the GSTP1 Ile105Val polymorphism were often studied in combination in many diseases because of their additive effects, but they were usually genotyped by two separate methods. AIM: The purpose of the present study was to develop a simple and reliable method to simultaneously detect these three polymorphisms.
METHODS: The three polymorphisms of 259 volunteers were genotyped using a multiplex polymerase chain reaction (PCR) method based on a tetra-primer amplification refractory mutation system-PCR (T-ARMS-PCR), and the results were validated by multiplex PCR for GSTM1 and GSTT1 polymorphisms and DNA sequencing of the GSTP1 Ile105Val polymorphism, respectively.
RESULTS: The multiplex PCR method of GSTM1, GSTT1, and GSTP1 polymorphisms based on T-ARMS-PCR can simultaneous detect the three polymorphisms in a single PCR. The results of this method are in perfect accord with the results of the multiplex PCR method of determining GSTM1, GSTT1 polymorphisms, and DNA sequencing of GSTP1 Ile105Val polymorphism.
CONCLUSION: The novel multiplex PCR method of GSTM1, GSTT1, and GSTP1 polymorphisms is simple, fast, low-cost, and reliable for the simultaneous detection of GSTM1, GSTT1, and GSTP1 Ile105Val polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24527777     DOI: 10.1089/gtmb.2013.0426

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  1 in total

1.  Development and validation of T-ARMS-PCR to detect CYP2C19*17 allele.

Authors:  Chenxi Jin; Zhikun Li; Xiaodi Zheng; Kailin Shen; Jiashuo Chao; Yifei Dong; Qin Huang; Qiulin Yin; Yan Deng; Weifeng Zhu
Journal:  J Clin Lab Anal       Date:  2019-08-22       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.